ARCHIVES

Alimta/Cisplatin Chemotherapy Increased Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

NCI Should Enhance Funding Of Centers Program, Porter Says

July 12, 1991

Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.

November 23, 2001